Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic association of lipids and lipid-lowering drug target genes with Endometrial carcinoma: a drug target Mendelian randomization study.

Frontiers in endocrinology - 1 Jan 2024

Yang Zhehan, Chen Junpan, Wen Minghao, Lei Jiayuan, Zeng Ming, Li Sichen, Long Yao, Zhou Zhiyi, Wang Chunyan

Abstract excerpt

Background: Aberrant lipid metabolism is intricately linked to the development of endometrial cancer, and statin lipid-lowering medications are regarded as promising adjunctive therapies for future management of this malignancy. This study employed Mendelian randomization (MR) to explore the causal association between lipid traits and endometrial cancer while assessing the potential impact of drug targets on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apolipoprotein B-100
Share to Cholesterol Ester Transfer Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endometrial Neoplasms

Share to Lipid Metabolism

Share to Lipids

Share to Mendelian Randomization Analysis

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 39193372
DOI: 10.3389/fendo.2024.1446457
PMCID: PMC11347345

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic association of lipids and lipid-lowering drug target genes with Endometrial carcinoma: a drug target Mendelian randomization study.PMID 39193372Read ↗

Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study.Semantic proximity Read ↗

Gene associations of lipid traits, lipid-lowering drug-target genes and endometriosis.Semantic proximity Read ↗

Genetic association of lipid and lipid-lowing drug targets with uterine fibroidsSemantic proximity Read ↗

Genetic variation perspective reveals potential drug targets for subtypes of endometrial cancerSemantic proximity Read ↗

Causal association between lipid-lowering drugs and cancers: A drug target Mendelian randomization study.Semantic proximity Read ↗

Genetically predicted triglyceride levels and endometriosis risk: Mendelian randomization with exploratory multi-omics analyses.Semantic proximity Read ↗

Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisationSemantic proximity Read ↗

Metabolomic signatures of lipid-modifying therapies using drug target Mendelian randomizationSemantic proximity Read ↗

Causal effects of lipid-lowering therapies on aging-related outcomes and risk of cancers: a drug-target Mendelian randomization study.Semantic proximity Read ↗

Evaluating the association between lipidome and female reproductive diseases through comprehensive Mendelian randomization analysesSemantic proximity Read ↗

Target Discovery for Drug Development Using Mendelian Randomization.Semantic proximity Read ↗

Genetic variation perspective reveals potential drug targets for subtypes of endometrial cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.